These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study. Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865 [TBL] [Abstract][Full Text] [Related]
37. A case of concomitant colitic cancer and intrahepatic cholangiocarcinoma during follow-up for ulcerative colitis. Tsuchiya K; Nanashima A; Ikeda T; Minami S; Nagano M; Hamada T; Yano K; Fujii Y Clin J Gastroenterol; 2017 Apr; 10(2):157-162. PubMed ID: 28138905 [TBL] [Abstract][Full Text] [Related]
38. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. de Vries AB; Janse M; Blokzijl H; Weersma RK World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965 [TBL] [Abstract][Full Text] [Related]
39. More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis. Claessen MM; Lutgens MW; van Buuren HR; Oldenburg B; Stokkers PC; van der Woude CJ; Hommes DW; de Jong DJ; Dijkstra G; van Bodegraven AA; Siersema PD; Vleggaar FP Inflamm Bowel Dis; 2009 Sep; 15(9):1331-6. PubMed ID: 19229982 [TBL] [Abstract][Full Text] [Related]